Center Laboratories (4123) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Center Laboratories (4123) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$46.61 Million ≈ $1.47 Million USD) by net assets (NT$19.64 Billion ≈ $618.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Center Laboratories stock valuation for the company's overall valuation and market capitalisation.
Center Laboratories - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Center Laboratories's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Center Laboratories Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Center Laboratories ranked by their cash flow conversion efficiency. Explore earnings quality score of Center Laboratories to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LIFETECH SCI.DL-00000125
F:81X
|
N/A |
|
Hemnet Group AB
ST:HEM
|
0.154x |
|
Momentum Group AB (publ)
ST:MMGR-B
|
0.046x |
|
Raymond Limited
NSE:RAYMOND
|
-0.011x |
|
Himalaya Shipping Ltd.
NYSE:HSHP
|
0.063x |
|
Bomesc Offshore Engineering Co
SHG:603727
|
0.022x |
|
Beijing Utour International Travel Service Co Ltd
SHE:002707
|
0.167x |
|
Shenzhen Jieshun Science and Technology Industry Co Ltd
SHE:002609
|
0.059x |
Annual Cash Flow Conversion Efficiency for Center Laboratories (2006–2024)
The table below shows the annual cash flow conversion efficiency of Center Laboratories from 2006 to 2024. View latest Center Laboratories stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$18.05 Billion ≈ $568.82 Million |
NT$415.71 Million ≈ $13.10 Million |
0.023x | +148.32% |
| 2023-12-31 | NT$20.22 Billion ≈ $636.92 Million |
NT$-963.44 Million ≈ $-30.35 Million |
-0.048x | -383.21% |
| 2022-12-31 | NT$19.25 Billion ≈ $606.55 Million |
NT$-189.88 Million ≈ $-5.98 Million |
-0.010x | +41.91% |
| 2021-12-31 | NT$21.09 Billion ≈ $664.61 Million |
NT$-358.14 Million ≈ $-11.28 Million |
-0.017x | -29.96% |
| 2020-12-31 | NT$20.63 Billion ≈ $650.10 Million |
NT$-269.56 Million ≈ $-8.49 Million |
-0.013x | +29.50% |
| 2019-12-31 | NT$15.46 Billion ≈ $487.02 Million |
NT$-286.45 Million ≈ $-9.02 Million |
-0.019x | -146.39% |
| 2018-12-31 | NT$15.47 Billion ≈ $487.30 Million |
NT$617.84 Million ≈ $19.47 Million |
0.040x | -66.54% |
| 2017-12-31 | NT$16.87 Billion ≈ $531.48 Million |
NT$2.01 Billion ≈ $63.44 Million |
0.119x | +63.44% |
| 2016-12-31 | NT$15.82 Billion ≈ $498.51 Million |
NT$1.16 Billion ≈ $36.41 Million |
0.073x | +886.07% |
| 2015-12-31 | NT$14.88 Billion ≈ $468.92 Million |
NT$-138.29 Million ≈ $-4.36 Million |
-0.009x | -754.87% |
| 2014-12-31 | NT$6.94 Billion ≈ $218.54 Million |
NT$-7.54 Million ≈ $-237.52K |
-0.001x | -113.13% |
| 2013-12-31 | NT$5.01 Billion ≈ $157.93 Million |
NT$41.50 Million ≈ $1.31 Million |
0.008x | +77.01% |
| 2012-12-31 | NT$3.47 Billion ≈ $109.32 Million |
NT$16.23 Million ≈ $511.33K |
0.005x | -85.23% |
| 2011-12-31 | NT$2.21 Billion ≈ $69.75 Million |
NT$70.11 Million ≈ $2.21 Million |
0.032x | +1890.25% |
| 2010-12-31 | NT$2.18 Billion ≈ $68.76 Million |
NT$-3.86 Million ≈ $-121.64K |
-0.002x | -109.56% |
| 2009-12-31 | NT$2.11 Billion ≈ $66.57 Million |
NT$39.11 Million ≈ $1.23 Million |
0.019x | -76.35% |
| 2008-12-31 | NT$573.09 Million ≈ $18.06 Million |
NT$44.86 Million ≈ $1.41 Million |
0.078x | -45.54% |
| 2007-12-31 | NT$471.17 Million ≈ $14.84 Million |
NT$67.71 Million ≈ $2.13 Million |
0.144x | +1.12% |
| 2006-12-31 | NT$273.07 Million ≈ $8.60 Million |
NT$38.81 Million ≈ $1.22 Million |
0.142x | -- |
About Center Laboratories
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antituss… Read more